Goldman initiated coverage on GE HealthCare with a new price target
$GEHC
Medical Electronics
Health Care
Goldman initiated coverage of GE HealthCare with a rating of Neutral and set a new price target of $87.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/7/2025 | $83.00 | Buy → Neutral | Citigroup |
| 5/5/2025 | $73.00 | Sell → Neutral | UBS |
| 3/11/2025 | $85.00 → $100.00 | Neutral → Buy | Goldman |
| 1/8/2025 | $95.00 → $103.00 | Hold → Buy | Jefferies |
| 9/26/2024 | $84.00 → $74.00 | Neutral → Sell | UBS |
| 9/18/2024 | $100.00 | Neutral → Buy | BTIG Research |
| 9/9/2024 | $90.00 | Neutral | JP Morgan |
| 8/6/2024 | $100.00 | Buy | Stifel |
144 - GE HealthCare Technologies Inc. (0001932393) (Subject)
144 - GE HealthCare Technologies Inc. (0001932393) (Subject)
SCHEDULE 13G - GE HealthCare Technologies Inc. (0001932393) (Subject)
Carestation 850 is designed to help health systems navigate the evolving landscape of anesthesia care now and in the future with an ergonomic design, continuously optimized algorithms, adaptable technologies and sustainable practices. With the goal of enhancing clinical precision, Carestation 850 features tools and customizable applications that are designed to help adapt to the needs of each patient, from neonates to the elderly. GE HealthCare will showcase Carestation 850 at booth #1314 during ANESTHESIOLOGY 2025 taking place from October 10-14, in San Antonio, Texas. GE HealthCare (NASDAQ:GEHC) today announced the unveiling of Carestation™ 850, its next-generation, FDA 510(k) p
GE HealthCare (NASDAQ:GEHC) will announce its third quarter 2025 financial results before the market opens on Wednesday, October 29, 2025. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also will be posted at the same link on the GE HealthCare Investor Relations website. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical te
Early adopters of Intelligent Radiation Therapy (iRT) to date have reduced simulation to treatment planning time from seven days to seven minutes1 via integration with RayStation® by RaySearch Laboratories The new version of iRT enhances connectivity, uses insights to improve efficiency, and includes a solution to manage workflows for the emerging field of theranostics GE HealthCare will spotlight its comprehensive radiation oncology portfolio at its booth, underscoring the company's commitment to accelerating global access to radiation therapy GE HealthCare (NASDAQ: GEHC) today announced updates to Intelligent Radiation Therapy (iRT), a new version of the company's software solut
4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
Citigroup downgraded GE HealthCare from Buy to Neutral and set a new price target of $83.00
UBS upgraded GE HealthCare from Sell to Neutral and set a new price target of $73.00
Goldman upgraded GE HealthCare from Neutral to Buy and set a new price target of $100.00 from $85.00 previously